Form D · Other
Codex Labs Corp
San Jose, CA · CIK 0002036789
Offering snapshot reported Sep 10, 2024 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 10, 2024 | Initial | $3,999,991 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-523678
Source: Form D, filed Sep 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Farmwald | Director |
| Sara Kaur | Executive |
| Barbara Paldus | Director, Executive |
| Robert Siegel | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1900 Camden Avenue, Suite 101
San Jose, CA, 95124
San Jose, CA, 95124